Generative and agentic artificial intelligence may be positioned to reshape the life sciences and healthcare (LSHC) landscape in 2026 and beyond. However, realizing the technology’s full ...

Life’s story may stretch further back than scientists once thought. Some genes found in nearly every organism today were already duplicated before all life shared a common ancestor. By tracking these ...

Artificial intelligence is no longer a promise of the future in the life sciences. It is quickly becoming a core competency for launching, scaling, and sustaining therapies. As the volume of data ...

The Research Triangle has been a major science and technology hub for decades. In 1984, as the tobacco and textiles industries–longstanding pillars of the North Carolina economy–moved overseas, ...

Achieve Life Sciences is a single-asset microcap centered on cytisinicline, with an accepted NDA and a June 20, 2026, PDUFA. Cytisinicline's α4β2 partial agonism aims to reduce cravings and blunt ...

A Dalai Lama once said that our prime purpose in this life is to help others – and he may have been right. Scientists have found that having a positive impact on other people seems to be a key element ...

Two major London life sciences schemes progressed this week as the sector recovers from a slow few years. A £500M mixed-use scheme involving a major life sciences component near King’s Cross was ...

European investment firm Gimv will no longer put funds into the life sciences sector, choosing instead to focus on its long-term investments and finding new value in four other key areas. The decision ...

BlueRidge Life Sciences (“BlueRidge”), a leading life sciences consulting and services platform and a portfolio company of Renovus Capital Partners, today announced the acquisition of Design Science, ...

In the life sciences and healthcare industries, the speed of innovation impacts how soon new products, medications and treatments make it to market—and, in turn, how quickly people are able to benefit ...

Chiba, Japan, January 12, 2026—A team at Japan’s National Institutes for Quantum Science and Technology (QST) has published a field-defining Perspective that places the societal payoff of quantum ...

Life sciences mergers and acquisitions surged back in force in 2025, as pharmaceutical and med-tech companies moved aggressively to shore up pipelines and offset looming revenue losses, according to ...